₹ 172.45
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Low dividends
Data is available to registered users only
Data is available to registered users only
About
Sanjivani Paranteral Ltd. is a pharmaceutical company that manufactures and supplies a variety of medical products. Its offerings include medications such as antibiotics, anti-emetics, anti-diabetics, and anti-fungals. The firm was established on October 5, 1994, by Anami H. Khemka, Ashwin A. Khemka, and Somesh Khemka, and its central operations are based in Mumbai, India.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Data is available to registered users only